Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Similar articles for PubMed (Select 16935294)

1.

Confirming human antibody responses to a therapeutic monoclonal antibody using a statistical approach.

Neyer L, Hiller J, Gish K, Keller S, Caras I.

J Immunol Methods. 2006 Aug 31;315(1-2):80-7. Epub 2006 Aug 7.

PMID:
16935294
2.

A novel gamma-fitting statistical method for anti-drug antibody assays to establish assay cut points for data with non-normal distribution.

Schlain B, Amaravadi L, Donley J, Wickramasekera A, Bennett D, Subramanyam M.

J Immunol Methods. 2010 Jan 31;352(1-2):161-8. doi: 10.1016/j.jim.2009.10.012. Epub 2009 Nov 3.

PMID:
19891969
3.

Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies.

Geng D, Shankar G, Schantz A, Rajadhyaksha M, Davis H, Wagner C.

J Pharm Biomed Anal. 2005 Sep 15;39(3-4):364-75. Review.

PMID:
15963677
4.

Clinical immunogenicity specificity assessments: a platform evaluation.

Peng K, Siradze K, Quarmby V, Fischer SK.

J Pharm Biomed Anal. 2011 Feb 20;54(3):629-35. doi: 10.1016/j.jpba.2010.09.035. Epub 2010 Oct 29.

PMID:
21035975
5.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
6.

Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.

Thybaud V, Aardema M, Clements J, Dearfield K, Galloway S, Hayashi M, Jacobson-Kram D, Kirkland D, MacGregor JT, Marzin D, Ohyama W, Schuler M, Suzuki H, Zeiger E; Expert Working Group on Hazard Identification and Risk Assessment in Relation to In Vitro Testing.

Mutat Res. 2007 Feb 3;627(1):41-58. Epub 2006 Nov 27.

PMID:
17126066
7.

How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.

Kirkland D, Pfuhler S, Tweats D, Aardema M, Corvi R, Darroudi F, Elhajouji A, Glatt H, Hastwell P, Hayashi M, Kasper P, Kirchner S, Lynch A, Marzin D, Maurici D, Meunier JR, Müller L, Nohynek G, Parry J, Parry E, Thybaud V, Tice R, van Benthem J, Vanparys P, White P.

Mutat Res. 2007 Mar 30;628(1):31-55. Epub 2007 Jan 13.

PMID:
17293159
8.

Improvement of drug tolerance in immunogenicity testing by acid treatment on Biacore.

Sickert D, Kroeger K, Zickler C, Chokote E, Winkler B, Grenet JM, Legay F, Zaar A.

J Immunol Methods. 2008 May 20;334(1-2):29-36. doi: 10.1016/j.jim.2008.01.010. Epub 2008 Feb 14.

PMID:
18304570
9.

Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.

Stubenrauch K, Wessels U, Lenz H.

J Pharm Biomed Anal. 2009 May 1;49(4):1003-8. doi: 10.1016/j.jpba.2009.01.030. Epub 2009 Feb 5.

PMID:
19250787
10.

Application of analytical detection concepts to immunogenicity testing.

Klakamp SL, Lu H, Tabrizi M, Funelas C, Roskos LK, Coleman D.

Anal Chem. 2007 Nov 1;79(21):8176-84. Epub 2007 Oct 9.

PMID:
17922557
11.

An Affinity Capture Elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drug.

Bourdage JS, Cook CA, Farrington DL, Chain JS, Konrad RJ.

J Immunol Methods. 2007 Oct 31;327(1-2):10-7. Epub 2007 Jul 27.

PMID:
17716682
12.

Complement dependent cytotoxicity (CDC) activity of a humanized anti Lewis-Y antibody: FACS-based assay versus the 'classical' radioactive method -- qualification, comparison and application of the FACS-based approach.

Nechansky A, Szolar OH, Siegl P, Zinoecker I, Halanek N, Wiederkum S, Kircheis R.

J Pharm Biomed Anal. 2009 May 1;49(4):1014-20. doi: 10.1016/j.jpba.2009.01.029. Epub 2009 Feb 4.

PMID:
19250790
13.

Assessing specificity for immunogenicity assays.

Swanson SJ, Chirmule N.

Bioanalysis. 2009 Jun;1(3):611-7. doi: 10.4155/bio.09.41. Review.

PMID:
21083156
14.

Antineutrophil cytoplasmic antibody measurement: advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISA.

O'Donnell JL, Hayman MW, Spellerberg MB, McLellan AD, Brooksbank K, Chapman PT, Stamp LK.

Pathology. 2007 Apr;39(2):258-63.

PMID:
17454758
15.
17.

Screening for coeliac disease using anti-tissue transglutaminase antibody assays, and prevalence of the disease in an Australian community.

Chin MW, Mallon DF, Cullen DJ, Olynyk JK, Mollison LC, Pearce CB.

Med J Aust. 2009 Apr 20;190(8):429-32.

PMID:
19374615
18.

Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays.

Tornetta M, Fisher D, O'Neil K, Geng D, Schantz A, Brigham-Burke M, Lombardo D, Fink D, Knight D, Sweet R, Tsui P.

J Immunol Methods. 2007 Dec 1;328(1-2):34-44. Epub 2007 Sep 4.

PMID:
17888945
19.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
20.

Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry.

Heudi O, Barteau S, Zimmer D, Schmidt J, Bill K, Lehmann N, Bauer C, Kretz O.

Anal Chem. 2008 Jun 1;80(11):4200-7. doi: 10.1021/ac800205s. Epub 2008 May 9.

PMID:
18465883
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk